Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Heartflow sues Cleerly | Outgoing SCAI president reflects on a busy year | FDA clears next-generation heart device

News You Need to Know Today
Heartflow sues Cleerly | Outgoing SCAI president reflects on a busy year | FDA clears next-generation heart device
Wednesday, April 15, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products. 

READ MORE >
AI lawsuit court legal
Share on Twitter Share on Facebook Share on Linkedin

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

Share on Twitter Share on Facebook Share on Linkedin
AI lawsuit court legal
According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products. 
READ MORE >

Outgoing SCAI president reflects on a busy year full of partnerships and advocacy

SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months. 

READ MORE >
Video interview with Society for Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, FACC, FAHA, MSCAI, explains the advancements in interventional cardiology the society has championed over the past year. #SCAI
Share on Twitter Share on Facebook Share on Linkedin

Outgoing SCAI president reflects on a busy year full of partnerships and advocacy

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Society for Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, FACC, FAHA, MSCAI, explains the advancements in interventional cardiology the society has championed over the past year. #SCAI
SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months. 
READ MORE >

FDA clears next-gen device for left-heart access

Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.

READ MORE >
Protaryx Transseptal Puncture Device
Share on Twitter Share on Facebook Share on Linkedin

FDA clears next-gen device for left-heart access

Share on Twitter Share on Facebook Share on Linkedin
Protaryx Transseptal Puncture Device
Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.
READ MORE >

Featured Articles

FDA shares warning about cath lab procedure kits due to risk of patient injury

The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

FDA shares warning about cath lab procedure kits due to risk of patient injury

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.
READ MORE >

New data highlight an unexpected link between hypercortisolism and resistant hypertension

Clinicians may need to broaden their diagnostic approach when treating and managing patients with resistant hypertension. 

READ MORE >
Deepak Bhatt discusses the MOMENTUM STUDY and the prevalence of hypercortisolism hypertension. #ACC #ACC26
Share on Twitter Share on Facebook Share on Linkedin

New data highlight an unexpected link between hypercortisolism and resistant hypertension

Share on Twitter Share on Facebook Share on Linkedin
Deepak Bhatt discusses the MOMENTUM STUDY and the prevalence of hypercortisolism hypertension. #ACC #ACC26
Clinicians may need to broaden their diagnostic approach when treating and managing patients with resistant hypertension. 
READ MORE >

More patients, fewer doctors: Demand keeps climbing as the cardiologist shortage continues

Job growth in cardiology is expected to outpace other healthcare specialties in the years ahead. The demand for new cardiologists is so high, however, that the current shortage is not expected to end anytime soon.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

More patients, fewer doctors: Demand keeps climbing as the cardiologist shortage continues

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Job growth in cardiology is expected to outpace other healthcare specialties in the years ahead. The demand for new cardiologists is so high, however, that the current shortage is not expected to end anytime soon.
READ MORE >

Stryker enters competitive IVL space with acquisition of Amplitude Vascular Systems

Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy. 

READ MORE >
AVS Pulse IVL
Share on Twitter Share on Facebook Share on Linkedin

Stryker enters competitive IVL space with acquisition of Amplitude Vascular Systems

Share on Twitter Share on Facebook Share on Linkedin
AVS Pulse IVL
Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy. 
READ MORE >

In Case You Missed It

Cardiovascular Business announces its Forty Under 40 Class of 2026

The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 

READ MORE >
cvb forty under 40 teaser
Share on Twitter Share on Facebook Share on Linkedin

Cardiovascular Business announces its Forty Under 40 Class of 2026

Share on Twitter Share on Facebook Share on Linkedin
cvb forty under 40 teaser
The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 
READ MORE >

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 

READ MORE >
overweight patient seeking health advice
Share on Twitter Share on Facebook Share on Linkedin

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Share on Twitter Share on Facebook Share on Linkedin
overweight patient seeking health advice
Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 
READ MORE >

FDA-approved surgical aortic valve implanted for first time in US

The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.

READ MORE >
corcym Perceval Plus LANCELOT
Share on Twitter Share on Facebook Share on Linkedin

FDA-approved surgical aortic valve implanted for first time in US

Share on Twitter Share on Facebook Share on Linkedin
corcym Perceval Plus LANCELOT
The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.
READ MORE >

In Other News

Rural hospital CEO talks Medicaid cuts, staffing challenges and the joys of community healthcare delivery

An exclusive interview with Scott Steiner, CEO of Phoebe Putney—a nonprofit health system that serves Southwest Georgia. 

READ MORE >
Phoebe Putney Memorial Hospital
Share on Twitter Share on Facebook Share on Linkedin

Rural hospital CEO talks Medicaid cuts, staffing challenges and the joys of community healthcare delivery

Share on Twitter Share on Facebook Share on Linkedin
Phoebe Putney Memorial Hospital
An exclusive interview with Scott Steiner, CEO of Phoebe Putney—a nonprofit health system that serves Southwest Georgia. 
READ MORE >

AMGA pushes back on Medicare Advantage payment adjustment and outlines needed reforms

The American Medical Group Association explains why it has issues with the payment adjustment for Medicare Advantage plans, arguing it fails to keep pace with the real-world costs.

READ MORE >
Darryl Drevna, senior director of regulatory affairs, American Medical Group Association (AMGA), explains why the group objects to a near-complete freeze in an annual payment adjustment for Medicare Advantage (MA) plans, arguing it fails to keep pace with the real-world costs of delivering care to Medicare patients.
Share on Twitter Share on Facebook Share on Linkedin

AMGA pushes back on Medicare Advantage payment adjustment and outlines needed reforms

Share on Twitter Share on Facebook Share on Linkedin
Darryl Drevna, senior director of regulatory affairs, American Medical Group Association (AMGA), explains why the group objects to a near-complete freeze in an annual payment adjustment for Medicare Advantage (MA) plans, arguing it fails to keep pace with the real-world costs of delivering care to Medicare patients.
The American Medical Group Association explains why it has issues with the payment adjustment for Medicare Advantage plans, arguing it fails to keep pace with the real-world costs.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout
FDA clears first surgical valve of its kind | Family files $17M lawsuit | BATMAN to the rescue | Major trends at SCCT 2026
Early reactions to proposed TAVR changes | Cardiology still an AI leader | More than 11K bottles of blood pressure drug recalled
TV star's family awarded $13M in malpractice case | Helping patients with ‘broken hearts’ | Cardiac amyloidosis in the spotlight
CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup